PubMed Health⌕ Search

Biomedical subjects

R Feng

Publications and source records attributed to R Feng.

58 records · Page 4Linked to original sources
PubMed1982

Hepatic damage in experimental and clinical paragonimiasis.

The hepatic damage induced by Paragonimus skrjabini, and the migration route of this species and that of P. westermani, were investigated in a series of animal experiments and in 34 clinical and four autopsy cases of paragonimiasis. The major symptoms and signs of an unique case reported from Sichuan Province included hepatic tenderness, disturbance of hepatic functions, remittent fever, and cough with bloody sputum. Laparotomy revealed marked adhesions surrounding the liver, spleen and duodenum. Diagnosis was made by finding P. skrjabini in a bulla on the abdominal wall about 5 months after the onset of illness. After specific treatment with bithional, body temperature and liver functions returned to normal. Twenty-three of 33 cases independently studied from Fujian Province also showed similar hepatic function disturbance. Autopsy cases showed hepatic chronic eosinophilic abscesses with Charcot-Leyden crystals. Experimentally, P. skrjabini infection caused hepatic damage in all laboratory animals used. The main pathologic changes were initially acute eosinophilic abscesses in the liver, worms being found sometimes in the necrotic cavities of the abscesses; hepatomagaly also occurred. Some cysts containing mature worms were found in the liver of dogs 3-9 months after infection. Numerous eggs were deposited in the cyst walls. The migration route of P. skrjabini was studied in young dogs. Worms appeared in the liver initially on day 3 and reached their highest level on day 14. P. westermani also migrated into liver, but their numbers were less than those of P. skrjabini.

Acute Disease↗
PubMedDate not supplied

Analysis of phase I and phase II metabolites of tamoxifen in breast cancer patients.

This study describes the application of LC/MS/MS to the determination of phase I and phase II metabolites of tamoxifen in urine and plasma samples of breast cancer patients. In the plasma extracts, in addition to the parent drug and N-desmethyltamoxifen, a minor metabolite tamoxifen N-oxide was identified for the first time in human. Four intact glucuronides of tamoxifen metabolites were isolated in the 24-hr posttreatment urine sample. They were the glucuronides of 4-hydroxytamoxifen, 4-hydroxy-N-desmethyltamoxifen, dihydroxytamoxifen, and a monohydroxy-N-desmethyltamoxifen. Hydroxylation followed by glucuronidation is a well-established metabolic route of tamoxifen, and this study describes for the first time direct analyses of these metabolites in human urine samples using on-line LC tandem MS.

Breast Neoplasms↗